MeSH term | MeSH ID | Detail |
---|---|---|
Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
Acne Vulgaris | D000152 | 35 associated lipids |
Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
Lung Neoplasms | D008175 | 171 associated lipids |
13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.
To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin
MeSH term | MeSH ID | Detail |
---|---|---|
Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
Acne Vulgaris | D000152 | 35 associated lipids |
Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
Lung Neoplasms | D008175 | 171 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Cakmakci A et al. | Polycythemia in a patient treated with isotretinoin. | 2001 Jul-Aug | Ann Pharmacother | pmid:11485156 |
Laroche ML et al. | Cerebral ischemia probably related to isotretinoin. | 2007 | Ann Pharmacother | pmid:17472998 |
Marroni M et al. | Isotretinoin: possible cause of acute seizure and confusion. | 1993 | Ann Pharmacother | pmid:8329809 |
Moeller KE and Touma SC | Prolonged thrombocytopenia associated with isotretinoin. | 2003 | Ann Pharmacother | pmid:14565796 |
Enders SJ and Enders JM | Isotretinoin and psychiatric illness in adolescents and young adults. | 2003 Jul-Aug | Ann Pharmacother | pmid:12841827 |
Reniers DE and Howard JM | Isotretinoin-induced inflammatory bowel disease in an adolescent. | 2001 | Ann Pharmacother | pmid:11675849 |
Cruz NI and Korchin L | Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. | 1994 | Ann Plast Surg | pmid:7810956 |
Yeo PM et al. | Paradoxical Worsening of Truncal Acne with Doxycycline. | 2016 | Ann. Acad. Med. Singap. | pmid:27748793 |
Börner AR et al. | Isotretinoin in metastatic thyroid cancer. | 1997 | Ann. Intern. Med. | pmid:9245241 |
Osborne C et al. | Isotretinoin in respiratory papillomatosis. | 2000 | Ann. Intern. Med. | pmid:10858163 |
Roach M | A malignant eccrine poroma responds to isotretinoin (13-cis-retinoic acid). | 1983 | Ann. Intern. Med. | pmid:6312862 |
Rodondi N et al. | High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. | 2002 | Ann. Intern. Med. | pmid:11955026 |
Summary for patients. An unusual "side effect" of an acne drug. | 2002 | Ann. Intern. Med. | pmid:11955046 | |
Friedland M et al. | Malignant eccrine poroma and isotretinoin. | 1984 | Ann. Intern. Med. | pmid:6322633 |
Flynn WJ et al. | Pancreatitis associated with isotretinoin-induced hypertriglyceridemia. | 1987 | Ann. Intern. Med. | pmid:3035979 |
Lippman SM and Meyskens FL | Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. | 1987 | Ann. Intern. Med. | pmid:3477106 |
Sakai Y et al. | 13-cis Retinoic acid (accutane) suppresses hippocampal cell survival in mice. | 2004 | Ann. N. Y. Acad. Sci. | pmid:15251924 |
Mestre JR et al. | Phorbol ester-mediated induction of cyclooxygenase-2 gene expression is inhibited by retinoids. | 1997 | Ann. N. Y. Acad. Sci. | pmid:9616751 |
Kooistra T et al. | Enhancement of tissue-type plasminogen activator levels by retinoids in rat tissues in vivo. | 1992 | Ann. N. Y. Acad. Sci. | pmid:1309036 |
Lippman SM and Hong WK | 13-cis-retinoic acid plus interferon-alpha in solid tumors: keeping the cart behind the horse. | 1994 | Ann. Oncol. | pmid:8075044 |
Toma S et al. | Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma. | 1994 | Ann. Oncol. | pmid:8075053 |
Cascinu S et al. | Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy. | 1996 | Ann. Oncol. | pmid:8839916 |
Dimery IW et al. | Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity. | 1997 | Ann. Oncol. | pmid:9093712 |
Goodwin WJ et al. | Inhibition of hamster tongue carcinogenesis by selenium and retinoic acid. | 1986 Mar-Apr | Ann. Otol. Rhinol. Laryngol. | pmid:3083753 |
Ohta A et al. | Retinoid modulation of collagenase production by adherent human mononuclear cells in culture. | 1987 | Ann. Rheum. Dis. | pmid:3036026 |
Rice D et al. | The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. | 2003 | Ann. Thorac. Surg. | pmid:14529975 |
Kudelka AP et al. | Metastatic adenocarcinoma of the endometrium treated with 13-cis-retinoic acid plus interferon-alpha. | 1993 | Anticancer Drugs | pmid:8358060 |
Recchia F et al. | Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma. | 2008 | Anticancer Drugs | pmid:18176117 |
Rinaldi DA et al. | Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer. | 1993 | Anticancer Drugs | pmid:8457712 |
Ruotsalainen T et al. | Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study. | 2000 | Anticancer Drugs | pmid:10789592 |
Gravis G et al. | Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma. | 1999 | Anticancer Drugs | pmid:10378671 |
Piamsomboon S et al. | Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature. | 1996 | Anticancer Drugs | pmid:8949994 |
Cabrespine A et al. | In vitro assessment of cytotoxic agent combinations for hormone-refractory prostate cancer treatment. | 2005 | Anticancer Drugs | pmid:15746578 |
Johanning GL et al. | Effect of high retinoid doses on RAR-beta mRNA expression in female B6D2F1 mice. | 2001 May-Jun | Anticancer Res. | pmid:11497248 |
Somos S and Farkas B | Immunomodulatory treatment with low-dose interferon-alpha and oral retinoic acid in lymphangioma-like Kaposi's sarcoma. | 2000 Jan-Feb | Anticancer Res. | pmid:10769722 |
Recchia F et al. | Immunotherapy in patients with less than complete response to chemotherapy. | 2009 | Anticancer Res. | pmid:19331204 |
Recchia F et al. | Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study. | 2000 May-Jun | Anticancer Res. | pmid:10928138 |
Somos S et al. | Cancer protection in xeroderma pigmentosum variant (XP-V). | 1999 May-Jun | Anticancer Res. | pmid:10472330 |
Toma S et al. | Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (alpha-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): a pilot study. | 1996 Mar-Apr | Anticancer Res. | pmid:8687154 |
Recchia F et al. | Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy. | 2005 Jul-Aug | Anticancer Res. | pmid:16080579 |
Kröger MJ et al. | Life quality of patients with metastatic renal cell carcinoma and chemo-immunotherapy--a pilot study. | 1999 Mar-Apr | Anticancer Res. | pmid:10365144 |
Isaacs CE et al. | Inhibition of herpes simplex virus replication by retinoic acid. | 1997 | Antiviral Res. | pmid:9021053 |
Pachajoa H and Ordoñez A | [Isotretinoin embryopathy with microtia-anotia and congenital heart disease: case report]. | 2012 May-Jun | Arch Argent Pediatr | pmid:22760759 |
Eimer L et al. | [Darier-White disease treated with oral isotretinoin]. | 2011 | Arch Argent Pediatr | pmid:21829859 |
DiGiovanna JJ et al. | Osteoporosis is a toxic effect of long-term etretinate therapy. | 1995 | Arch Dermatol | pmid:7503569 |
Weiss J et al. | Bilateral corneal opacities. Occurrence in a patient treated with oral isotretinoin. | 1981 | Arch Dermatol | pmid:6938168 |
Katz RA | Isotretinoin treatment of recalcitrant warts in an immunosuppressed man. | 1986 | Arch Dermatol | pmid:3455807 |
McElwee NE et al. | An observational study of isotretinoin recipients treated for acne in a health maintenance organization. | 1991 | Arch Dermatol | pmid:1825596 |
Leachman SA et al. | Bone densities in patients receiving isotretinoin for cystic acne. | 1999 | Arch Dermatol | pmid:10456346 |
Newton RC et al. | Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus. | 1986 | Arch Dermatol | pmid:3511858 |